Status
Conditions
Treatments
About
This is an observational safety study of a prophylactic use of Flu Egg Derived Adjuvanted Swine Origin A(H1N1) Vaccine in subjects 6 months of age and older. Subjects may receive either 1 or 2 doses: children and elderly will receive 2 doses and adults will receive either 1 or 2 doses.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Received any prior H1N1 vaccination
7,284 participants in 6 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal